Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York, USA.
Ann N Y Acad Sci. 2011 Nov;1237:88-94. doi: 10.1111/j.1749-6632.2011.06217.x.
Inflammation plays a key role in excessive bone loss in conditions such as rheumatoid arthritis and periodontitis. An important paradigm in immunology is that inflammatory factors activate feedback inhibition mechanisms to restrain inflammation and limit associated tissue damage. We hypothesized that inflammatory factors would activate similar feedback mechanisms to restrain bone loss in inflammatory settings. We have identified three mechanisms that inhibit osteoclastogenesis and are induced by inflammatory factors such as toll-like receptor ligands and cytokines; downregulation of expression of costimulatory molecules such as TREM-2; induction of shedding, and thereby inactivation of the M-CSF receptor c-Fms, leading to decreased RANK transcription; and induction of transcriptional repressors such as interferon regulatory factor 8. It is likely that these mechanisms work in a complementary and cooperative manner to fine tune the extent of osteoclastogenesis in inflammatory settings, and their augmentation may represent an alternative therapeutic approach to suppress bone resorption.
炎症在类风湿关节炎和牙周炎等疾病中骨量过度丢失中起着关键作用。免疫学中的一个重要范式是,炎症因子激活反馈抑制机制来抑制炎症并限制相关的组织损伤。我们假设炎症因子会激活类似的反馈机制来抑制炎症环境中的骨丢失。我们已经确定了三种抑制破骨细胞生成的机制,这些机制是由炎症因子如 Toll 样受体配体和细胞因子诱导的;共刺激分子如 TREM-2 的表达下调;M-CSF 受体 c-Fms 的脱落和失活,从而导致 RANK 转录减少;以及转录抑制因子如干扰素调节因子 8 的诱导。这些机制可能以互补和协作的方式来精细调节炎症环境中破骨细胞生成的程度,它们的增强可能代表抑制骨吸收的另一种治疗方法。